Top

Published in:

01-10-2013 | Original Paper

Correlates of Retention in HIV Care After Release from Jail: Results from a Multi-site Study

Authors: Amy L. Althoff, Alexei Zelenev, Jaimie P. Meyer, Jeannia Fu, Shan-Estelle Brown, Panagiotis Vagenas, Ann K. Avery, Jacqueline Cruzado-Quiñones, Anne C. Spaulding, Frederick L. Altice

Published in: AIDS and Behavior | Special Issue 2/2013

Abstract

Retention in care is key to effective HIV treatment, but half of PLWHA in the US are continuously engaged in care. Incarcerated individuals are an especially challenging population to retain, and empiric data specific to jail detainees is lacking. We prospectively evaluated correlates of retention in care for 867 HIV-infected jail detainees enrolled in a 10-site demonstration project. Sustained retention in care was defined as having a clinic visit during each quarter in the 6 month post-release period. The following were independently associated with retention: being male (AOR = 2.10, p ≤ 0.01), heroin use (AOR 1.49, p = 0.04), having an HIV provider (AOR 1.67, p = 0.02), and receipt of services: discharge planning (AOR 1.50, p = 0.02) and disease management session (AOR 2.25, p ≤ 0.01) during incarceration; needs assessment (AOR 1.59, p = 0.02), HIV education (AOR 2.03, p ≤ 0.01), and transportation assistance (AOR 1.54, p = 0.02) after release. Provision of education and case management services improve retention in HIV care after release from jail.

Centers for Disease Control and Prevention. Advancing HIV prevention initiative. Centers for Disease Control and Prevention; 2005.

Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.PubMedCrossRef

Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis. 2008;198(1):59–67.PubMedCrossRef

Joint United Nations Programme on HIV/AIDS. Getting to zero. 2010.

Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010;24(17):2665–78.PubMedCrossRef

Giordano TP, Gifford AL, White AC, Suarez-Almazor ME, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493–9.PubMedCrossRef

Chen NE, Meyer JP, Avery AK, Draine J, Flanigan TP, Lincoln T, et al. Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav. 2011. doi:10.1007/s10461-011-0080-2.

Meyer JP, Chen NE, Springer SA. HIV treatment in the criminal justice system: critical knowledge and intervention gaps. AIDS Res Treat. 2011;2011:680617.PubMed

Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754–60.PubMedCrossRef

10.

Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120(1):84–8.PubMed

11.

Baillargeon JG, Giordano TP, Harzke AJ, Baillargeon G, Rich JD, Paar DP. Enrollment in outpatient care among newly released prison inmates with HIV infection. Public Health Rep. 2010;125(Suppl 1):64–71.PubMed

12.

Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301(8):848–57.PubMedCrossRef

13.

Baillargeon J, Giordano TP, Harzke AJ, Spaulding AC, Wu ZH, Grady JJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS. 2010;24(6):389–94.PubMedCrossRef

14.

Pai NP, Estes M, Moodie EE, Reingold AL, Tulsky JP. The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail. PLoS One. 2009;4(9):e7115.PubMedCrossRef

15.

Draine J, Ahuja D, Altice FL, Arriola KJ, Avery AK, Beckwith CG, et al. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011;23(3):366–77.PubMedCrossRef

16.

Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. 2011.

17.

Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.PubMedCrossRef

18.

Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.PubMed

19.

McLellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise D. The addiction severity index at 25: origins, contributions and transitions. Am J Addict. 2006;15(2):113–24.PubMedCrossRef

20.

McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33.PubMedCrossRef

21.

McGahan P, Griffith J, Parente R, McLellan T. Addiction severity index composite score manual. The University of Pennsylvania/Veterans Administration Center for Studies of Addiction. 1986.

22.

Calsyn DA, Saxon AJ, Bush KR, Howell DN, Baer JS, Sloan KL, et al. The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug Alcohol Depend. 2004;76(2):165–71.PubMedCrossRef

23.

de Voux A, Spaulding AC, Beckwith C, Avery A, Williams C, Messina LC, et al. Early identification of HIV: empirical support for jail-based screening. PLoS One. 2012;7(5):e37603.PubMedCrossRef

24.

Macgowan R, Margolis A, Richardson-Moore A, Wang T, Lalota M, French PT, et al. Voluntary rapid human immunodeficiency virus (HIV) testing in jails. Sex Transm Dis. 2009;36(Suppl 2):S9–13.PubMed

25.

Jackman S. Estimation and inference via Bayesian simulation: an introduction to Markov Chain Monte Carlo. Am J Pol Sci. 2000;44:375–404.CrossRef

26.

Manfred J, editor. On testing the missing at random assumption. Berlin: Springer; 2006.

27.

Enders CK. Applied missing data analysis. New York: Guilford Press; 2010.

28.

Fu J, Herme M, Wickersham J, Zelenev A, Althoff A, Zaller N, et al. Understanding the revolving door: factors associated with recidivism among HIV-infected jail detainees. AIDS Behav. 2012.

29.

Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(5):651–81.PubMedCrossRef

30.

DHHS Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. 2009.

31.

Vlahov D, Putnam S. From corrections to communities as an HIV priority. J Urban Health. 2006;83(3):339–48.PubMedCrossRef

32.

Stephenson BL, Wohl DA, McKaig R, Golin CE, Shain L, Adamian M, et al. Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS. 2006;17(2):103–8.PubMedCrossRef

33.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef

34.

Stone VE. HIV/AIDS in women and racial/ethnic minorities in the U.S. Curr Infect Dis Rep. 2012;14(1):53–60.PubMedCrossRef

35.

Maruschak L. HIV in prisons, 2007–2008. U.S. Department of Justice: Bureau of Justice Statistics; 2009, contract no. NCJ 228307.

36.

Jones AS, Lillie-Blanton M, Stone VE, Ip EH, Zhang Q, Wilson TE, et al. Multi-dimensional risk factor patterns associated with non-use of highly active antiretroviral therapy among human immunodeficiency virus-infected women. Womens Health Issues. 2010;20(5):335–42.PubMedCrossRef

37.

Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis. 2009;199(7):991–8.PubMedCrossRef

38.

Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, et al. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis. 2011;203(4):442–51.PubMedCrossRef

39.

Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48(2):248–56.PubMedCrossRef

40.

Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012;60(1):77–82.PubMedCrossRef

41.

Springer SA, Chen S, Altice F. Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Care. 2009;21(8):976–83.PubMedCrossRef

42.

Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.PubMed

43.

Traeger L, O’Cleirigh C, Skeer MR, Mayer KH, Safren SA. Risk factors for missed HIV primary care visits among men who have sex with men. J Behav Med. 2012;35(5):548–56.PubMedCrossRef

44.

James DJ. Bureau of Justice Statistics Special Report: Profile of Jail Inmates, 2002. U.S. Department of Justice; 2004, contract no. NCJ 201932.

45.

Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.PubMedCrossRef

46.

Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.PubMedCrossRef

47.

Milloy MJ, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.PubMedCrossRef

48.

Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.PubMedCrossRef

49.

Vlassova N, Angelino AF, Treisman GJ. Update on mental health issues in patients with HIV infection. Curr Infect Dis Rep. 2009;11(2):163–9.PubMedCrossRef

50.

Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423–31.PubMedCrossRef

51.

Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817–33.PubMedCrossRef

52.

Flanigan TP, Kim JY, Zierler S, Rich J, Vigilante K, Bury-Maynard D. A prison release program for HIV-positive women: linking them to health services and community follow-up. Am J Public Health. 1996;86(6):886–7.PubMedCrossRef

53.

Hammett T, Kennedy S, Kuck S. National survey of infectious diseases in correctional facilities’ HIV and sexually transmitted diseases: US Department of Justice (unpublished data). Department of Justice; 2007, contract no. NCJ 217736.

54.

Zaller ND, Fu JJ, Nunn A, Beckwith CG. Linkage to care for HIV-infected heterosexual men in the United States. Clin Infect Dis. 2011;52(Suppl 2):S223–30.PubMedCrossRef

Title: Correlates of Retention in HIV Care After Release from Jail: Results from a Multi-site Study
Authors: Amy L. Althoff
Alexei Zelenev
Jaimie P. Meyer
Jeannia Fu
Shan-Estelle Brown
Panagiotis Vagenas
Ann K. Avery
Jacqueline Cruzado-Quiñones
Anne C. Spaulding
Frederick L. Altice
Publication date: 01-10-2013
Publisher: Springer US
Published in: AIDS and Behavior / Issue Special Issue 2/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-012-0372-1

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Correlates of Retention in HIV Care After Release from Jail: Results from a Multi-site Study

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2013

Transitional Care Coordination in New York City Jails: Facilitating Linkages to Care for People with HIV Returning Home from Rikers Island

Linkage to HIV Care for Jail Detainees: Findings From Detention to the First 30 Days After Release

Planning for Success Predicts Virus Suppressed: Results of a Non-Controlled, Observational Study of Factors Associated with Viral Suppression Among HIV-Positive Persons Following Jail Release

Understanding the Revolving Door: Individual and Structural-Level Predictors of Recidivism Among Individuals with HIV Leaving Jail

Post-Release Substance Abuse Outcomes Among HIV-Infected Jail Detainees: Results from a Multisite Study

HIV-Positive and in Jail: Race, Risk Factors, and Prior Access to Care

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page